1. Recommendations for the treatment of invasive fungal infection caused by filamentous fungi in the hematological patient.
- Author
-
Barberán J, Mensa J, Llamas JC, Ramos IJ, Ruiz JC, Marín JR, Tello PB, Massana MB, Vidal JB, Viñas JM, Huelva FJ, Pons EC, Mediavilla JD, Morfa ML, Barrigón FE, Avellán PF, López SG, García CG, Maraver DH, Guía AL, Jiménez JL, Chacón EM, Rubio MO, Oteyza JP, Ramírez GR, Contreras RR, Barbero AR, Tarrats MR, Félix DR, Godoy PS, Salinas AS, Alonso MA, Torroba Jde L, Ferreiras DV, López LV, García JM, Perea JR, Moreno RC, Cáncer RC, Abete JF, Rodríguez JG, Gómez JG, Pedrosa EG, Baranda JM, García FJ, Camps IR, Lleti MS, and Cisneros Jde L
- Subjects
- Humans, Leukemia complications, Mycoses microbiology, Myelodysplastic Syndromes complications, Risk, Antifungal Agents therapeutic use, Hematologic Diseases complications, Mycoses complications, Mycoses drug therapy
- Abstract
Antifungal treatment in the hematological patient has reached a high complexity with the advent of new antifungals and diagnostic tests, which have resulted in different therapeutic strategies. The use of the most appropriate treatment in each case is essential in infections with such a high mortality. The availability of recommendations as those here reported based on the best evidence and developed by a large panel of 48 specialists aimed to answer when is indicated to treat and which agents should be used, considering different aspects of the patient (risk of fungal infection, clinical manifestations, galactomanann test, chest CT scan and previous prophylaxis) may help clinicians to improve the results.
- Published
- 2011